Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
08 February 2007Website:
http://www.accuray.comNext earnings report:
09 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 20:20:00 GMTDividend
Analysts recommendations
Institutional Ownership
ARAY Latest News
The Radixact System will be supplied with ClearRT®, Synchrony®, and the VOLO™ Ultra Optimizer to enhance radiation treatment delivery precision and speed Heidelberg University Hospital is recognized worldwide for excellence in patient care and practice changing research MADISON, Wis. , June 27, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that long-term customer Heidelberg University Hospital in Heidelberg, Germany, has selected the company's Radixact ® System, equipped with its proprietary ClearRT ®, Synchrony ® and VOLO™ Ultra Optimizer solutions, to help transform their approach to cancer care.
Accuray (ARAY) announces an agreement with TrueNorth to provide radiation oncology departments with third-party support designed to improve their department's capabilities.
MADISON, Wis. , June 20, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an agreement with TrueNorth Medical Physics LLC to provide radiation oncology departments with third-party support designed to enhance their department's capabilities.
Accuray (ARAY) announces the approval of the Accuray Precision Treatment Planning System by the Chinese Medical Products Administration.
ASGN, ARAY and BGS have been added to the Zacks Rank #5 (Strong Sell) List on May 31, 2023.
DDD, ARAY and BNTGY have been added to the Zacks Rank #5 (Strong Sell) List on May 24, 2023.
MADISON, Wis. , May 22, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2024.
Despite performing well in radiation oncology, Accuray (ARAY) announces disappointing financial results for the third quarter of fiscal year 2024.
Accuray Incorporated (NASDAQ: ARAY) will be hosting their Q3 2024 Earnings Conference Call on May 1, 2024 at 4:30 PM ET. The call will be led by Jesse Chew, SVP and Chief Legal Officer, Suzanne Winter, President and CEO, and Ali Pervaiz, CFO. Participants include Young Li from Jefferies, Brooks O'Neil from Lake Street, and Jason Wittes from ROTH MKM. The conference call is set to review the financial results for the third quarter of fiscal year 2024, which concluded on March 31, 2024. All attendees will be in listen-only mode.
Accuray (ARAY) reported a quarterly loss of $0.06 per share, which was higher than the expected loss of $0.01 per share according to the Zacks Consensus Estimate. This is a decrease from earnings of $0.01 per share in the same quarter last year.
- 1(current)
- 2
What type of business is Accuray Incorporated?
Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.
What sector is Accuray Incorporated in?
Accuray Incorporated is in the Healthcare sector
What industry is Accuray Incorporated in?
Accuray Incorporated is in the Medical Devices industry
What country is Accuray Incorporated from?
Accuray Incorporated is headquartered in United States
When did Accuray Incorporated go public?
Accuray Incorporated initial public offering (IPO) was on 08 February 2007
What is Accuray Incorporated website?
https://www.accuray.com
Is Accuray Incorporated in the S&P 500?
No, Accuray Incorporated is not included in the S&P 500 index
Is Accuray Incorporated in the NASDAQ 100?
No, Accuray Incorporated is not included in the NASDAQ 100 index
Is Accuray Incorporated in the Dow Jones?
No, Accuray Incorporated is not included in the Dow Jones index
When does Accuray Incorporated report earnings?
The next expected earnings date for Accuray Incorporated is 09 August 2024